Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
P/E ratio for Greenbrook TMS Inc. (GBNH)
P/E ratio as of 2022: -0.52
According to Greenbrook TMS Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.52. At the end of 2021 the company had a P/E ratio of -2.21.
P/E ratio history for Greenbrook TMS Inc. from 2015 to 2022
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2022 | -0.52 |
| 2021 | -2.21 |
| 2020 | -0.79 |
| 2019 | -1.21 |
| 2018 | -3.24 |
| 2017 | -6.21 |
| 2016 | -7.65 |
| 2015 | -6.83 |